Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 538-545

  Zuliani, Giovanni ^a   Morieri, Mario Luca ^a   Volpato, Stefano ^a   Maggio, Marcello ^b   Cherubini, Antonio ^c   Francesconi, Daniela ^a   Bandinelli, Stefania ^d,e   Paolisso, Giuseppe ^f   Guralnik, Jack M ^g   Ferrucci, Luigi ^h  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Institute of Gerontology and Geriatrics INNRCA   (Italy)

^d ASF Geriatric Rehabilitation   (Italy)

^e IOT   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

C reactive protein; Elderly; Insulin resistance; Metabolic syndrome; Mortality

Indexed keywords

C REACTIVE PROTEIN; INSULIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CLINICAL CHEMISTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASE; COMPLICATION; EPIDEMIOLOGY; INFLAMMATION; ITALY; METABOLISM; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; ITALY; MALE; METABOLIC SYNDROME X; PHENOTYPE; RISK;

EID: 84910059901     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.959     Document Type: Article

References (39)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 Dec, 37(12):1595-1607.
2. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004 Sep 7, 110(10):1245-1250.
3. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. JAm Coll Cardiol 2010 Sep 28, 56(14):1113-1132.
4. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002 Jan 16, 287(3):356-359.
5. Mozaffarian D., Kamineni A., Prineas R.J., Siscovick D.S. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008 May 12, 168(9):969-978.
6. Zambon S., Zanoni S., Romanato G., Corti M.C., Noale M., Sartori L., et al. Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study. Diabetes Care 2009 Jan, 32(1):153-159.
7. Akbaraly T.N., Kivimaki M., Ancelin M.L., Barberger-Gateau P., Mura T., Tzourio C., et al. Metabolic syndrome, its components, and mortality in the elderly. JClin Endocrinol Metab 2010 Nov, 95(11):E327-E332.
8. Rachas A., Raffaitin C., Barberger-Gateau P., Helmer C., Ritchie K., Tzourio C., et al. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Heart 2012 Apr, 98(8):650-655.
9. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic finns. Eur Heart J 2007 Apr, 28(7):857-864.
10. Sattar N., McConnachie A., Shaper A.G., Blauw G.J., Buckley B.M., de Craen A.J., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008 Jun 7, 371(9628):1927-1935.
11. Butler J., Rodondi N., Zhu Y., Figaro K., Fazio S., Vaughan D.E., et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. JAm Coll Cardiol 2006 Apr 18, 47(8):1595-1602.
12. Hildrum B., Mykletun A., Dahl A.A., Midthjell K. Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trondelag Health Study (HUNT). Diabetologia 2009 Apr, 52(4):583-590.
13. Thomas F., Pannier B., Benetos A., Vischer U.M. The impact of the metabolic syndrome-but not of hypertension-on all-cause mortality disappears in the elderly. JHypertens 2011 Apr, 29(4):663-668.
14. Sundstrom J., Riserus U., Byberg L., Zethelius B., Lithell H., Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006 Apr 15, 332(7546):878-882.
15. Ausk K.J., Boyko E.J., Ioannou G.N. Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care 2010 Jun, 33(6):1179-1185.
16. Perseghin G., Calori G., Lattuada G., Ragogna F., Dugnani E., Garancini M.P., et al. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol 2012 Dec, 49(6):421-428.
17. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007 Feb, 30(2):318-324.
18. de Boer I.H., Katz R., Chonchol M.B., Fried L.F., Ix J.H., Kestenbaum B., et al. Insulin resistance, cystatin C, and mortality among older adults. Diabetes Care 2012 Jun, 35(6):1355-1360.
19. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int 2000 Oct, 58(4):1703-1710.
20. Hassinen M., Lakka T.A., Komulainen P., Gylling H., Nissinen A., Rauramaa R. C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care 2006 Apr, 29(4):931-932.
21. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002 Mar 5, 105(9):1135-1143.
22. Libby P. Inflammation in atherosclerosis. Nature 2002 Dec 19, 420(6917):868-874.
23. Buckley D.I., Fu R., Freeman M., Rogers K., Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009 Oct 6, 151(7):483-495.
24. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino R.B., Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004 Jul 27, 110(4):380-385.
25. Elkind M.S., Luna J.M., Moon Y.P., Liu K.M., Spitalnik S.L., Paik M.C., et al. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology 2009 Oct 20, 73(16):1300-1307.
26. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999 May, 106(5):506-512.
27. Cushman M., Arnold A.M., Psaty B.M., Manolio T.A., Kuller L.H., Burke G.L., et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005 Jul 5, 112(1):25-31.
28. Giovannini S., Onder G., Liperoti R., Russo A., Carter C., Capoluongo E., et al. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. JAm Geriatr Soc 2011 Sep, 59(9):1679-1685.
29. Ferrucci L., Bandinelli S., Benvenuti E., Di I.A., Macchi C., Harris T.B., et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. JAm Geriatr Soc 2000 Dec, 48(12):1618-1625.
30. Zuliani G., Galvani M., Maggio M., Volpato S., Bandinelli S., Corsi A.M., et al. Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance. Atherosclerosis 2010 Nov, 213(1):319-324.
31. Pearson T.A., Bazzarre T.L., Daniels S.R., Fair J.M., Fortmann S.P., Franklin B.A., et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003 Feb 4, 107(4):645-651.
32. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 Oct 25, 112(17):2735-2752.
33. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 Dec 17, 106(25):3143-3421.
34. Barnett K.N., McMurdo M.E., Ogston S.A., Morris A.D., Evans J.M. Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review. Age Ageing 2006 Sep, 35(5):463-468.
35. Lee J.K., Bettencourt R., Brenner D., Le T.A., Barrett-Connor E., Loomba R. Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study. PLoS One 2012, 7(4):e34218.
36. Laaksonen D.E., Niskanen L., Nyyssonen K., Punnonen K., Tuomainen T.P., Salonen J.T. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J 2005 Sep, 26(17):1783-1789.
37. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006 Dec 14, 444(7121):881-887.
38. Boren J., Taskinen M.R., Olofsson S.O., Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. JIntern Med 2013 Jul, 274(1):25-40.
39. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 Jan, 23(1):57-63.